Alnylam Pharmaceuticals, Inc. (BMV:ALNY)

Alnylam Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,114	966.43	812.69	866.39	819.98	496.58
Short-Term Investments	1,744	1,728	1,627	1,326	1,616	1,378
Cash & Short-Term Investments	2,858	2,695	2,439	2,192	2,436	1,874
Cash Growth	8.88%	10.46%	11.27%	-9.98%	29.94%	22.02%
Accounts Receivable	567.11	405.31	327.79	237.96	198.57	102.41
Other Receivables	-	-	-	-	-	500
Total Trade Receivables	567.11	405.31	327.79	237.96	198.57	602.41
Inventory	71.69	78.51	89.15	128.96	86.36	75.2
Other Current Assets	147.31	116.96	126.38	132.92	88.08	62.77
Total Current Assets	3,644	3,295	2,983	2,692	2,809	2,615
Net Property, Plant & Equipment	692.19	693.93	725.79	738.63	733.63	706.51
Long-Term Investments	68.59	68.59	49.39	49.39	40.89	40.73
Other Long-Term Assets	161.54	182.17	72	66.09	60.2	45.05
Total Assets	4,566	4,240	3,830	3,546	3,643	3,407
Accounts Payable	102.39	88.42	55.52	98.09	73.43	51.97
Accrued Expenses	918.97	793.69	713.01	545.46	395.17	355.91
Current Portion of Leases	46.1	41.89	41.51	41.97	40.55	36.87
Unearned Revenue	15.08	55.48	102.75	42.11	149.48	127.21
Other Current Liabilities	218.31	206.8	54.99	40.29	37.08	13.32
Total Current Liabilities	1,301	1,186	967.79	767.92	695.71	585.27
Long-Term Debt	1,027	1,025	1,021	1,017	675.7	191.28
Long-Term Leases	224.45	229.54	243.1	261.34	281.35	293.04
Other Long-Term Liabilities	1,764	1,732	1,819	1,658	1,402	1,321
Total Long-Term Liabilities	3,015	2,987	3,083	2,937	2,359	1,806
Total Liabilities	4,315	4,173	4,051	3,705	3,055	2,391
Common Stock	1.31	1.29	1.26	1.24	1.2	1.16
Additional Paid-in Capital	7,691	7,388	6,811	6,455	6,058	5,644
Accumulated Other Comprehensive Income	-29.95	-34.52	-23.38	-44.65	-33.26	-43.62
Retained Earnings	-7,412	-7,288	-7,010	-6,569	-5,438	-4,585
Shareholders' Equity	250.59	67.09	-220.64	-158.22	588.2	1,016
Total Liabilities & Equity	4,566	4,240	3,830	3,546	3,643	3,407
Total Debt	1,297	1,296	1,305	1,320	997.59	521.19
Net Cash (Debt)	1,561	1,398	1,134	872.16	1,438	1,353
Net Cash Growth	11.59%	23.32%	30.02%	-39.35%	6.26%	9.81%
Net Cash Per Share	12.05	10.96	9.08	7.17	12.14	11.77
Book Value	250.59	67.09	-220.64	-158.22	588.2	1,016
Book Value Per Share	1.93	0.53	-1.77	-1.30	4.97	8.84
Tangible Book Value	250.59	67.09	-220.64	-158.22	588.2	1,016
Tangible Book Value Per Share	1.93	0.53	-1.77	-1.30	4.97	8.84

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.